Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.91 SEK 1.67% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vicore Pharma Holding AB
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Total Liabilities & Equity
kr478.7m
CAGR 3-Years
-8%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Total Liabilities & Equity
kr2.3B
CAGR 3-Years
7%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Total Liabilities & Equity
kr778.7m
CAGR 3-Years
31%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Total Liabilities & Equity
kr16.9B
CAGR 3-Years
40%
CAGR 5-Years
52%
CAGR 10-Years
41%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Total Liabilities & Equity
kr72.2B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
27%
BioArctic AB
STO:BIOA B
Total Liabilities & Equity
kr1.2B
CAGR 3-Years
4%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.94 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Vicore Pharma Holding AB's Total Liabilities & Equity?
Total Liabilities & Equity
478.7m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Total Liabilities & Equity amounts to 478.7m SEK.

What is Vicore Pharma Holding AB's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
12%

Over the last year, the Total Liabilities & Equity growth was 41%. The average annual Total Liabilities & Equity growth rates for Vicore Pharma Holding AB have been -8% over the past three years , 12% over the past five years .

Back to Top